Erste Asset Management GmbH increased its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 106.2% during the fourth quarter, Holdings Channel reports. The fund owned 64,110 shares of the financial services provider’s stock after acquiring an additional 33,026 shares during the quarter. Erste Asset Management GmbH’s holdings in CME Group were worth $17,850,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of CME. Empowered Funds LLC boosted its position in CME Group by 11.5% during the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after acquiring an additional 1,037 shares during the last quarter. Marshall Wace LLP boosted its position in CME Group by 103.1% during the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after acquiring an additional 121,707 shares during the last quarter. Federated Hermes Inc. boosted its position in CME Group by 1,325.2% during the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after acquiring an additional 21,918 shares during the last quarter. Nebula Research & Development LLC acquired a new stake in CME Group during the second quarter worth approximately $992,000. Finally, The Manufacturers Life Insurance Company boosted its position in CME Group by 2.6% during the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after acquiring an additional 7,397 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.
CME Group Stock Down 2.1%
Shares of CME opened at $252.03 on Tuesday. The firm has a market cap of $91.33 billion, a PE ratio of 21.50, a price-to-earnings-growth ratio of 2.88 and a beta of 0.21. The company’s fifty day moving average is $287.43 and its two-hundred day moving average is $288.47. CME Group Inc. has a fifty-two week low of $244.56 and a fifty-two week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.1%. CME Group’s payout ratio is presently 44.37%.
Analysts Set New Price Targets
A number of analysts recently issued reports on CME shares. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday. Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, April 26th. Jefferies Financial Group decreased their price target on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a report on Thursday, April 16th. Finally, Piper Sandler lifted their price target on shares of CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a report on Wednesday, April 15th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $305.29.
Check Out Our Latest Stock Analysis on CME
Insider Activity at CME Group
In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares in the company, valued at approximately $2,397,597.04. The trade was a 31.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider owned 27,702 shares in the company, valued at $8,438,860.26. The trade was a 17.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 44,044 shares of company stock worth $13,297,507. 0.30% of the stock is currently owned by corporate insiders.
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
See Also
- Five stocks we like better than CME Group
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
